EBV-Positive and EBV-Negative Posttransplant Diffuse Large B Cell Lymphomas Have Distinct Genomic and Transcriptomic Features-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

EBV-Positive and EBV-Negative Posttransplant Diffuse Large B Cell Lymphomas Have Distinct Genomic and Transcriptomic Features

Published:2016-01-18 Issue:2 Volume:16 Page:414-425
ISSN:1600-6135
Container-title:American Journal of Transplantation
language:en
Short-container-title:

Author:

Finalet Ferreiro J.¹,Morscio J.²,Dierickx D.³,Vandenberghe P.¹,Gheysens O.⁴,Verhoef G.³,Zamani M.¹,Tousseyn T.²,Wlodarska I.¹

Affiliation:

1. Center for Human Genetics; KU Leuven Leuven Belgium

2. Translational Cell and Tissue Research KU Leuven; Department of Pathology UZ Leuven; Leuven Belgium

3. Department of Hematology; UZ Leuven Leuven Belgium

4. Department of Molecular Medicine; UZ Leuven Leuven Belgium

Funder

KU Leuven

Fonds Wetenschappelijk Onderzoek

Stichting Tegen Kanker

University Hospitals Leuven

Publisher

Wiley

Subject

Pharmacology (medical),Transplantation,Immunology and Allergy

Reference38 articles.

1. Characteristic pattern of chromosomal imbalances in posttransplantation lymphoproliferative disorders: Correlation with histopathological subcategories and EBV status;Poirel;Transplantation,2005

2. Comparative genome-wide profiling of post-transplant lymphoproliferative disorders and diffuse large B-cell lymphomas;Rinaldi;Br J Haematol,2006

3. Single nucleotide polymorphism-arrays provide new insights in the pathogenesis of post-transplant diffuse large B-cell lymphoma;Rinaldi;Br J Haematol,2010

4. Gene expression profiling reveals clear differences between EBV-positive and EBV-negative posttransplant lymphoproliferative disorders;Morscio;Am J Transplant,2013

Cited by 68 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. First Use of Upfront Polatuzumab Vedotin in Post-transplant Lymphoproliferative Disorder: A Case Report;Cureus;2024-03-18

2. Immune deficiency/dysregulation -associated lymphoproliferative disorders. Revised classification and management;Blood Reviews;2024-03

3. Post-Transplant Lymphoproliferative Disorders;Seminars in Nephrology;2024-01

4. Transplantation Pathology;MacSween's Pathology of the Liver;2024

5. How I treat posttransplant lymphoproliferative disorder;Blood;2023-10-26

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3